About Aditi Ganguly
Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do's and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities.
Aditi's fascination with the stock market began in college, where she majored in Economics, while researching The Great Recession for her thesis. After graduating, she began her career handling the content requirements for the mutual fund aggregator Groww. Since then she has become a financial journalist that focuses on writing articles that educate retail investors about the equity markets and the global economy.
Recent Articles By Aditi Ganguly
Should You Buy the Dip in American International Group?
The share price of American Insurance Group (AIG) has declined marginally over the past month, following the release of its divestiture plans and on mixed analyst sentiment. So, will the company be able to beat the Street’s expectations and deliver stellar financials in the about-to-be-reported quarter? Read more to find out.
The Bullish Case for Cemex
Mexico-based cement manufacturer CEMEX (CX) looks well-positioned to benefit from the reopening of construction activities globally. And we think the company’s solid financials and impressive growth prospects make it an ideal investment bet now.
3 Stocks Yielding More Than 3%
Concerns regarding decelerating economic growth are expected to offset bullish market sentiment, causing the benchmark indexes to retreat soon. Given this backdrop, we think investing in fundamentally sound dividend-paying companies could help hedge the systematic risk. Vale (VALE), Dow (DOW), and OneMain Holdings (OMF) pay dividends that yield more than 3%. So, let’s evaluate these names more closely.
2 Healthcare Stocks Wall Street Predicts Will Rally by 40% or More
The healthcare industry’s relatively inelastic demand and its crucial role in fighting the COVID-19 pandemic will likely make it a popular choice for investors seeking to hedge their portfolios against a possible market correction. Given genomics’ and technology-based healthcare products’ explosive growth potential, Wall Street analysts expect Invitae (NVTA) and OPKO Health (OPK) to deliver tremendous upside in the near term. Read on.
After Reporting Q2 Earnings, is Facebook or Pinterest a Better Social Media Stock to Buy?
Social media behemoths Facebook (FB) and Pinterest (PINS) have generated stellar growth since last year. While FB in its last reported quarter registered its fastest revenue growth since 2016, PINS reported a triple-digit rise in revenues for its last reported quarter. But which stock is the better buy now? Let’s find out.
The Bearish Case for Support.com
Technical support provider Support.com’s (SPRT) highly anticipated merger with vertically integrated bitcoin mining company Greenidge Generation has boosted its popularity with retail investors. As one of the latest meme stocks in the market, its stock has generated double-digit gains over the past five days. But we think complexities regarding this merger and high short interest make the stock best avoided now. Read on.
Should Zynga be in Your Portfolio?
As part of its long-term growth strategy, social games developer Zynga (ZNGA) recently acquired two companies. However, given its premium valuation and low-profit margins, is ZNGA a valuable addition to one’s portfolio now? Read more to find out.
2 Natural Gas Stocks Wall Street Predicts Will Rally by More Than 25%
Natural gas prices are currently hovering near three-year highs because the historic heatwave in the United States this summer is raising concerns about tight supplies later in the year. Soaring energy demand and tight supply worldwide should cause prices of the commodity to rise further. As such, Wall Street analysts expect natural gas stock EQT (EQT) and Cabot Oil & Gas (COG) to gain more than 25% in the near term.
The Bullish Case for Abbott Laboratories
Abbott Laboratories (ABT) is a renowned player in the medical devices and ancillary healthcare products industry with an impressive dividend payout history. We think the company’s stable growth outlook makes it an ideal investment bet amid the resurgence of COVID-19 cases and surging market volatility. Let's discuss.